H. O. Douglass - Concepedia

Author

H. O. Douglass

Roswell Park Comprehensive Cancer Center

Also Known As

H Douglass, H O Douglass, H. Douglass, H. O. DOUGLASS, H. O. Douglass, H.O. DOUGLASS, H.O. Douglass, H.O. Douglass, Jr., HO Douglass, Harold O. Douglass

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center University at Buffalo, State University of New York SUNY Downstate Health Sciences University

About

H. O. Douglass is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	2K
2	Gastroenterology	9	9	1.1K
3	Health Sciences	4	4	173
4	Biochemistry	1	1	54
5	Cell Biology	1	1	162

H. O. Douglass

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. Nicholas J. Petrelli, H. O. Douglass, L Herrera, Journal of Clinical Oncology Chemoprevention StrategyGastrointestinal OncologyMedicineMetastatic Colorectal CarcinomaPharmacology	1989	554
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. P Engstrom, Philip T. Lavin, C G Moertel, Journal of Clinical Oncology Metastatic Carcinoid TumorGastrointestinal OncologyMedicinePharmacologyPathology	1984	266
Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer Donald M. Stablein, H. O. Douglass Cancer Surgical OncologyGastrointestinal OncologyMedian SurvivalMedicineCurative Resection	1982	183
Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites W H Chen, Julius S. Horoszewicz, Susan S. Leong, In Vitro Cellular & Developmental Biology - Plant New Tumor LineTumoral PathologyVivo MorphologyPancreatic CancerPathology	1982	162
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group report Philip S. Schein, Philip T. Lavin, Charles G. Moertel, Cancer Surgical OncologyOncologyPancreatic CancerPartial ResponseMedian Survival	1978	106
An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). H. O. Douglass, Philip T. Lavin, Anouk Goudsmit, Journal of Clinical Oncology Mitomycin CCancer ManagementGastroenterologyPathologyPharmacotherapy	1984	104
Osteosarcoma associated with osteopoikilosis. Eugene R. Mindell, C S Northup, H. O. Douglass Journal of Bone and Joint Surgery Bone DiseaseSurgical PathologyHistopathologyPathologyMedicine	1978	98
Etoposide pharmacokinetics in patients with normal and abnormal organ function. Susan G. Arbuck, H. O. Douglass, W R Crom, Journal of Clinical Oncology Pharmacokinetic ModelingHepatologyLiver PhysiologyPharmacologyLaboratory Medicine	1986	96
Is taste related to anorexia in cancer patients? AS Trant, J Serin, H. O. Douglass American Journal of Clinical Nutrition ObesityNutritionFood IntolerancePathologyCancer Patients	1982	64
A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. Susan G. Arbuck, H. O. Douglass, Fabio Trave, Journal of Clinical Oncology Surgical OncologyPhase Ii TrialGastrointestinal OncologyMedicineMetronomic Therapy	1987	61

Page 1